The purpose of this study was to investigate the growth-promoting effects of four rhizobacterial isolates (RS60, RS65, RS46, and RP6) isolated from the tomato rhizosphere. These isolates were screened for key plant growth-promoting rhizobacteria (PGPR) mechanisms, including ammonia production, nitrogen fixation, phosphate solubilization, indole-3-acetic acid (IAA) production, and siderophore synthesis. Their potential to enhance seed germination and tomato plant growth was investigated in controlled and greenhouse conditions. Four isolates exhibited multiple PGPR attributes, notably IAA and ammonia production as well as phosphate solubilization. The results revealed that these strains significantly enhanced tomato seed germination and shoot growth in vitro, with RS65 showing the highest germination rate (70%). However, no significant differences in early seedling responses were observed under greenhouse conditions when compared to the control. Thirty days after inoculation, greenhouse results revealed that the four studied strains significantly increased growth metrics including shoot length, number of leaves, collar diameter, and dry weight. The isolate RP6 showed a significant effect on the growth of the plant, with an average shoot length of 34.40 cm and nine leaves per plant. In vitro antagonism assays demonstrated that isolates RS60, RS65, and RP6 effectively inhibited the growth of Botrytis cinerea, Alternaria alternata, and Oidium lycopersici, with inhibition rates exceeding 65%. These antagonistic activities were linked to the production of hydrolytic enzymes (chitinase, cellulase, pectinase, protease), siderophores, and hydrogen cyanide (HCN). Molecular identification through 16S rRNA gene sequencing confirmed the isolates as Bacillus cereus (RS60), Bacillus pumilus (RS46), Bacillus amyloliquefaciens (RP6), and Bacillus velezensis (RS65), each showing over 97% sequence similarity with reference strains. These findings underscore the potential of the selected Bacillus spp. as promising biofertilizers and biocontrol agents for sustainable tomato cultivation and support their inclusion in integrated disease and nutrient management strategies.

This study aimed to investigate the biocontrol activity of rhizosphere isolates against late blight disease of tomatoes caused by the fungus Phytophthora infestans. A total of 30 rhizospheric bacterial isolates were evaluated for their antagonistic activity against P. infestans in vitro and in vivo. The results demonstrated that among the 30 isolates tested, six (RS65, RP6, RS47, RS46, RP2, and RS61) exhibited a highly significant inhibitory effect (p < 0.001) on the mycelial growth of P. infestans in vitro, with the inhibition rate exceeding 67%. Among the isolates, RS65 exhibited the highest inhibition rate at 78.48%. For antagonistic mechanisms, the results demonstrated that the six isolates exhibited significant enzymatic activity, including proteolytic, lipolytic, and chitinolytic activity, as well as the production of HCN, cellulase, and pectinase. Isolate RS65, which showed the highest inhibition rate, was further evaluated under greenhouse conditions. This investigation revealed significant differences in the severity of late blight between the control and the RS65 treatment. The control showed a severity level of 31.26%, whereas the RS65 treatment achieved the lowest severity of 16.54%. Molecular identification results indicated that the RS65 isolate (accession numbers PV208381) is a Bacillus genus with 99% proximity to Bacillus velezensis. This finding suggests that the Bacillus RS65 treatment could provide effective protection against P. infestans infection in tomato plants. These findings highlight the potential of Bacillus RS65 as a biocontrol agent in integrated disease management for tomato late blight.

The COVID-19 pandemic has reignited interest in traditional medicinal plants as potential therapeutic agents. This study examined the chemical composition, cytotoxicity, and antimicrobial activity of essential oils from six Moroccan medicinal plants, namely, Eucalyptus globulus, Artemisia absinthium, Syzygium aromaticum, Thymus vulgaris, Artemisia alba, and Santolina chamaecyparissus, which are commonly used by the Moroccan population for COVID-19 prevention. The chemical composition of each essential oil was determined using gas chromatography–mass spectrometry (GC–MS) to identify key compounds. Cytotoxicity was evaluated in the Vero E6 cell line, which is frequently used in SARS-CoV-2 research, using the neutral red assay, with oil concentrations ranging from 25 to 100 µg/mL. Antimicrobial activity was tested against standard reference strains, including Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923), Candida albicans (ATCC 10231), and Bacillus subtilis (ATCC 6633), using the disc diffusion method. GC–MS analysis revealed significant components such as spathulenol (15%) and caryophyllene oxide (7.67%) in Eucalyptus globulus and eugenol (54.96%) in Syzygium aromaticum. Cytotoxicity assays indicated that higher concentrations of essential oils significantly reduced cell viability, with Thymus vulgaris showing the highest IC₅₀ (8.324 µM) and Artemisia absinthium the lowest (18.49 µM). In terms of antimicrobial activity, Eucalyptus globulus had the strongest effect, with a 20 ± 0.00 mm inhibition zone against Bacillus subtilis, whereas both Syzygium aromaticum and Artemisia herba-alba had a 12.25 ± 0.1 mm inhibition zone against the same strain. These findings suggest that these essential oils have significant therapeutic potential, particularly in combating antimicrobial resistance and exerting cytotoxic effects on viral cell lines. Further research is necessary to explore their mechanisms of action and ensure their safety for therapeutic use.

Background: Gastroparesis, a chronic digestive disorder characterized by delayed gastric emptying, often results from diabetes, post-surgical complications, autoimmune diseases, and neurological disorders. In approximately 50% of cases, the cause is idiopathic gastroparesis (IGD). Recent studies suggest a link between chronic enteroviral infection and persistent gastrointestinal symptoms, including delayed gastric emptying. This study investigates the effects of a silydianin-rich extract from Silybum marianum seeds on enteroviral infections in vitro and the mitigation of delayed gastric emptying in mice. Silydianin, a key bioactive compound known for its liver-protective and antioxidant properties, has not been extensively studied for its impact on enteroviral infections and gastroparesis. Methods: NMR spectroscopy (¹H, ¹³C, DEPT 135 and 2D, and HSQC) and HRMS identified silydianin as the primary compound, with minor flavonolignans. This study assessed the cytotoxicity and antiviral activity of the extract at various stages of the viral life cycle, including virucidal activity, cell protection, and post-infection effects, using neutral red assays in RD cells, with results confirmed by real-time PCR. The viruses studied included coxsackievirus B2, coxsackievirus A10, poliovirus SL-1, and enterovirus EV71. The impact on delayed gastric emptying was evaluated in a mouse model using doses of 100 and 200 mg/kg compared to a control group receiving physiological saline. Results: The silydianin-rich extract showed consistent antiviral activity, with the highest selectivity index (SI) for EV71 (4.08) during virucidal activity. It provided moderate cell protection, with EC₅₀ values ranging from 120.88 to 186.10 µg/mL and SI values from 2.20 to 3.39. Post-infection treatment showed varying efficacy, with coxsackie A10 demonstrating the highest SI (3.90). In vivo, the extract at 200 mg/kg significantly improved gastric emptying to 96.47% and slightly increased gastrointestinal transit from 50.33% to 61.46%. Conclusions: These results suggest that silydianin may be effective for treating enteroviral infections and enhancing intestinal function, making it a promising candidate for gastroparesis treatment and warranting further research.

This study analyzes the nutritional quality and mycotoxin contamination of three key feed ingredients—corn, soybean meal (SBM), and sunflower meal (SFM)—imported into Morocco during the years 2019, 2020, and 2021. Samples were collected upon reception at the plant and analyzed in triplicate under standardized laboratory conditions. Chemical composition was evaluated using classical and NIR-based methods, while mycotoxin levels were assessed through ELISA and confirmed by HPLC. Corn samples from Argentina, Brazil, and Ukraine were assessed for their proximate composition and mycotoxin burden. While most nutritional parameters showed no significant differences between origins (p > 0.05), water activity (Aw) and digestible threonine content were significantly affected by origin (p < 0.01). Brazilian corn had the highest Aw (0.716), followed by Argentina (0.680), and Ukraine (0.662), a factor linked to its higher susceptibility to mold and mycotoxin development. Soybean meal from the U.S. and Argentina showed a general positive trend in favor of U.S. imports, with higher average crude protein (the CP content of American soybean meal was 46.912%, compared to 46.610% in Argentine soybean meal), fat, digestible lysine, and metabolizable energy. However, statistical differences were limited to water activity and moisture content (p < 0.05). American soybean meals are generally recognized for their consistent processing quality and superior amino acid digestibility. Sunflower meal, sourced exclusively from Ukraine, showed a steady improvement in crude protein (from 35.97% in 2019 to 36.99% in 2021) and metabolizable energy, alongside reduced crude fiber content, enhancing its nutritional value in poultry diets. The consistent use of Ukrainian SFM in Morocco reflects both supply stability and quality. Regarding mycotoxins, origin had a significant effect on several compounds. Argentine and Brazilian corn showed higher mean levels of fumonisins (1165.26 and 1019.52 ppb), ochratoxin A (2.26 and 3.02 ppb), and zearalenone (36.99 and 21.92 ppb) compared to Ukrainian corn, which consistently had the lowest levels across all major mycotoxins (e.g., fumonisins = 200 ppb; zearalenone = 4.90 ppb). Aflatoxin B1 levels remained constant at 0.2 ppb across all origins. These findings confirm the influence of geographic origin—particularly water activity—on mycotoxin risk in imported maize.

Background/Objectives Gastroparesis, a chronic digestive disorder characterized by delayed gastric emptying, often results from diabetes, post-surgical complications, autoimmune diseases, and neurological disorders. In approximately 50% of cases, the cause is idiopathic gastroparesis (IGD). Recent studies suggest a link between chronic enteroviral infections and persistent gas-trointestinal symptoms, including delayed gastric emptying. This study investigates the effects of a silydianin-rich extract from Silybum marianum seeds on enteroviral infections in vitro and the mitigation of delayed gastric emptying in mice. Silydianin, a key bioactive compound known for its liver-protective and antioxidant properties, has not been extensively studied for its impact on enteroviral infections and gastroparesis; Methods NMR spectroscopy (¹H, ¹³C, and DEPT) identi-fied silydianin as the primary compound, with minor flavonolignans and trace amounts of an oxidation product. The study assessed the cytotoxicity and antiviral activity of the extract at various stages of the viral life cycle, including virucidal activity, cell protection, and post-infection effects, using neutral red assays in RD cells, with results confirmed by real-time PCR. The viruses studied included Coxsackievirus B2, Coxsackievirus A10, Poliovirus SL-1, and Enterovirus EV71. The impact on delayed gastric emptying was evaluated in a mouse model of gastroparesis using doses of 100 and 200 mg/kg compared to a control; Results: The silydianin-rich extract exhibited con-sistent antiviral activity, with the highest selectivity index (SI) for EV71 (4.08) during virucidal activity. It provided moderate cell protection, with EC50 values ranging from 120.88 to 186.10 µg/mL and SI values from 2.20 to 3.39. Post-infection treatment showed varying efficacy, with Coxsackie A10 demonstrating the highest SI (3.90). In vivo, the extract at 200 mg/kg significantly improved gastric emptying to 96.47% and slightly increased gastrointestinal transit from 50.33% to 61.46%; Conclusions These results suggest that silydianin may be effective in treating enteroviral infections and enhancing intestinal function, making it a promising candidate for gastroparesis treatment and warranting further research.